Butterfly Network
BFLY
Market cap $569M

2.30 USD

-0.14

5.74%

At close Jun 13, 4:00 PM EDT

After hours

2.31

+0.01

0.43%

1 day

-5.74%

5 days

-9.09%

1 month

-3.36%

3 months

-9.80%

6 months

-32.15%

Year to date

-42.07%

1 year

149.38%

5 years

-76.77%

10 years

-76.77%

About: Butterfly Network Inc is a digital health business transforming care with handheld, whole-body ultrasound. Powered by its proprietary Ultrasound-on-Chip technology, its solution enables the acquisition of imaging information from an affordable, powerful device that fits in a healthcare professional's pocket with a combination of cloud-connected software and hardware technology that is easily accessed through a mobile application. The company enables the practical application of ultrasound information in the clinical workflow. Butterfly iQ+ is an ultrasound device that can perform whole-body imaging in a single handheld probe using semiconductor technology. With its small, handheld size, low cost, and simple user interface.

Employees: 190

Healthcare Medical Devices

0

Funds holding %

of 7,296 funds

–

Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

146% more first-time investments, than exits

New positions opened: 59 | Existing positions closed: 24

84% more repeat investments, than reductions

Existing positions increased: 68 | Existing positions reduced: 37

41% more call options, than puts

Call options by funds: $2.05M | Put options by funds: $1.45M

19% more funds holding

Funds holding: 171 [Q4 2024] → 204 (+33) [Q1 2025]

8.19% more ownership

Funds ownership: 38.97% [Q4 2024] → 47.16% (+8.19%) [Q1 2025]

3% more capital invested

Capital invested by funds: $227M [Q4 2024] → $233M (+$5.87M) [Q1 2025]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q4 2024] → 1 (+0) [Q1 2025]

See Fund Rankings

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target

$4

74%

upside

Avg. target

$4

74%

upside

High target

$4

74%

upside

1 analyst rating

1 positive

100%

0 neutral

0%

0 negative

0%

Lake Street

Ben Haynor

74%upside

$4

Buy

Maintained

5 May 2025

See Analyst Rankings

Financial journalist opinion

Based on 3 articles about BFLY published over the past 30 days

Butterfly Network's RoHS Lead Exemption Revocation Request Progresses to Stakeholder and Consultant Assessment

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (“Butterfly”, “the Company”) (NYSE: BFLY), a digital health company transforming care with handheld, whole-body ultrasound, today announced that the European Commission has officially initiated the review and stakeholder consultation period for the Company's request to revoke Annex IV n. 14 of the European Commission's Restriction of Hazardous Substances (RoHS) Directive – a temporary exemption historically granted for lead.

Butterfly Network's RoHS Lead Exemption Revocation Request Progresses to Stakeholder and Consultant Assessment

Zacks Investment Research

Tempus AI vs. Butterfly: Which AI Health Tech Stock is the Better Buy?

BFLY outpaces TEM with stronger upside, leaner valuation, and expanding global reach in AI-powered diagnostics.

Tempus AI vs. Butterfly: Which AI Health Tech Stock is the Better Buy?

Butterfly Network to Participate at William Blair 45th Annual Growth Stock Conference

NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”) a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that Joseph DeVivo, President, Chief Executive Officer and Chairman will present and host one-on-one investor meetings at William Blair 45th Annual Growth Stock Conference. The presentation will take place on Thursday, June 5, 2025, at 8:00 am CT in Chicago, IL. A live webcast of.

Butterfly Network to Participate at William Blair 45th Annual Growth Stock Conference

Butterfly Network: Speculative Potential For This 20% Revenue Grower

Butterfly Networks offers innovative, portable ultrasound devices which is driving strong double-digit revenue growth. Butterfly has a sound strategy of targeting medical students to encourage life-long product loyalty. The company is not yet profitable and there are multiple risks to be aware of.

Butterfly Network: Speculative Potential For This 20% Revenue Grower

Butterfly Network, Inc. (BFLY) Q1 2025 Earnings Call Transcript

Butterfly Network, Inc. (NYSE:BFLY ) Q1 2025 Results Conference Call May 2, 2025 8:00 AM ET Company Participants Heather Getz - Chief Financial & Operations Officer Joseph DeVivo - Chairman, Chief Executive Officer Conference Call Participants Andrew Brackmann - William Blair Josh Jennings - TD Cowen Suraj Kalia - Oppenheimer & Company Benjamin Haynor - Lake Street Capital Operator Good morning, and welcome to the Butterfly Network First Quarter 2025 Earnings Call. My name is Carla, and I will be coordinating your call today.

Butterfly Network, Inc. (BFLY) Q1 2025 Earnings Call Transcript

Zacks Investment Research

Butterfly Network, Inc. (BFLY) Reports Q1 Loss, Misses Revenue Estimates

Butterfly Network, Inc. (BFLY) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to loss of $0.07 per share a year ago.

Butterfly Network, Inc. (BFLY) Reports Q1 Loss, Misses Revenue Estimates

Butterfly Network Reports First Quarter 2025 Financial Results

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly” or the “Company”), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, today announced financial results for the first quarter ended March 31, 2025, and provided a business update. Joseph DeVivo, Butterfly's President, Chief Executive Officer and Chairman commented, “2025 is off to a great start. The Butterfly team hit the mark.

Butterfly Network Reports First Quarter 2025 Financial Results

Zacks Investment Research

3 Medical Info Systems Stocks to Ride the AI Wave in Trump Tariff Era

Zacks Medical Info Systems industry stocks like VEEV, HIMS and BFLY are expected to gain from the Stargate Project and provide relief amid tariff tension.

3 Medical Info Systems Stocks to Ride the AI Wave in Trump Tariff Era

Butterfly Network to Report First Quarter 2025 Financial Results on May 2, 2025

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, announced that it will report first quarter 2025 financial results on May 2, 2025 before the market opens. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and Heather Getz, Executive Vice President and Chief Financial and Operations Officer, will.

Butterfly Network to Report First Quarter 2025 Financial Results on May 2, 2025

Zacks Investment Research

Beyond Tempus AI: 2 Health IT Stocks Poised for Growth in 2025

AI-driven healthcare companies like Butterfly Network and Health Catalyst have all the qualities to emerge as the next big players.

Beyond Tempus AI: 2 Health IT Stocks Poised for Growth in 2025

See News Rankings

Charts implemented using Lightweight Charts™